Gil Awada
13PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Oct 07, 2024
Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAFV600/NRASQ61 Wild-Type Melanoma (TraMel-WT).Gil Awada, Iris Dirven, Julia Katharina Schwarze
|Feb 11, 2023
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study.Giuseppe Fasolino, Gil Awada, Laura Moschetta
|Sep 16, 2022
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial.Julia Katharina Schwarze, Jens Tijtgat, Gil Awada
|Feb 15, 2022
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.Julia Katharina Schwarze, Soizic Garaud, Yanina J L Jansen
|Jun 25, 2021
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.Johnny Duerinck, Julia Katharina Schwarze, Gil Awada
Pageof 3
Frequent Collaborators
11 joint publications
Bart Neyns
8 joint publications
Julia Katharina Schwarze
3 joint publications
Yanina Jansen
3 joint publications
Jens Tijtgat
2 joint publications
Anne Rogiers
2 joint publications
Marleen Keyaerts
1 joint publications
A A M van der Veldt
1 joint publications
Jennifer De Cremer
1 joint publications
Peter Theuns
1 joint publications
Mark De Ridder
